To determine whether the inhibitory effect on renal cancer cell survival by pharmacological inhibition of GSK-3 was specific to GSK-3β, we depleted GSK-3α or GSK-3β expression in ACHN cancer cells using siRNA (Figure 3E). This evidence concerns the gene GSK3A and cancer.